Inspiration Biopharmaceuticals renegotiates deal with French biotech firm Ipsen and comes out $50m better off with another $165m waiting in the wings.
Inspiration Biopharmaceuticals has renegotiated the terms of its strategic alliance with France-based biotech firm Ipsen, in a deal that will see Inspiration receive $50m with another potential $165m waiting in the pipeline.
Under the terms of the new deal, US-based Inspiration will receive $30m upfront with a promise of a further $20m from Ipsen upon the completion of a $30m external financing round. The additional $165m has been made available to Inspiration for hitting milestones and development targets.
Once Inspiration…
